Advertisement
Screener

BIOCLINICA INC Increase (Decrease) in Accounts Receivable

BIOCLINICA INC Increase (Decrease) in Accounts Receivable

BIOCLINICA INC reported Increase (Decrease) in Accounts Receivable of $6.28 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-22.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2013-02-22

  • BIOCLINICA INC increase (decrease) in accounts receivable for the quarter ending 2012-12-31 was $3.65M, a 25.65% increase year-over-year.
  • BIOCLINICA INC increase (decrease) in accounts receivable for the quarter ending 2012-09-30 was $3.16M.
  • BIOCLINICA INC increase (decrease) in accounts receivable for the quarter ending 2012-06-30 was -$1.00M, a 150.17% decline year-over-year.
  • BIOCLINICA INC increase (decrease) in accounts receivable for the quarter ending 2012-03-31 was $473.00K, a 39.20% decline year-over-year.
  • BIOCLINICA INC increase (decrease) in accounts receivable for fiscal 2012 was $6.28M, a 39.27% increase from fiscal 2011.
  • BIOCLINICA INC increase (decrease) in accounts receivable for fiscal 2011 was $4.51M, a 644.96% increase from fiscal 2010.
  • BIOCLINICA INC increase (decrease) in accounts receivable for fiscal 2010 was $605.00K.
  • BIOCLINICA INC increase (decrease) in accounts receivable for fiscal 2009 was -$1.80M.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 month
2012-12-31$3.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$6.81M
derived: sum of 2 quarters · filed 2013-02-22
$5.80M
derived: sum of 3 quarters · filed 2013-02-22
$6.28M
10-K · filed 2013-02-22
2012-09-30$3.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$2.15M
derived: sum of 2 quarters · filed 2012-11-09
$2.63M
10-Q · filed 2012-11-09
$5.53M
derived: sum of 4 quarters · filed 2013-02-22
2012-06-30-$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
-$532.00K
10-Q · filed 2012-08-09
$2.37M
derived: sum of 3 quarters · filed 2013-02-22
$1.19M
derived: sum of 4 quarters · filed 2013-02-22
2012-03-31$473.00K
10-Q · filed 2012-05-10
$3.38M
derived: sum of 2 quarters · filed 2013-02-22
$2.20M
derived: sum of 3 quarters · filed 2013-02-22
$4.20M
derived: sum of 4 quarters · filed 2013-02-22
2011-12-31$2.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$1.73M
derived: sum of 2 quarters · filed 2013-02-22
$3.73M
derived: sum of 3 quarters · filed 2013-02-22
$4.51M
10-K · filed 2013-02-22
2011-09-30-$1.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$825.00K
derived: sum of 2 quarters · filed 2012-11-09
$1.60M
10-Q · filed 2012-11-09
$2.49M
derived: sum of 4 quarters · filed 2013-02-22
2011-06-30$2.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$2.78M
10-Q · filed 2012-08-09
$3.66M
derived: sum of 3 quarters · filed 2013-02-22
$3.53M
derived: sum of 4 quarters · filed 2013-02-22
2011-03-31$778.00K
10-Q · filed 2012-05-10
$1.66M
derived: sum of 2 quarters · filed 2013-02-22
$1.53M
derived: sum of 3 quarters · filed 2013-02-22
2010-12-31$883.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$752.00K
derived: sum of 2 quarters · filed 2013-02-22
$605.00K
10-K · filed 2013-02-22
2010-09-30-$131.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
-$278.00K
10-Q · filed 2011-11-14
2010-06-30-$147.00K
10-Q · filed 2011-08-08
2009-12-31-$1.80M
10-K · filed 2012-02-27